drug

PGx testing guided treatment (PGT)

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BIOLOGICAL
Pre-approval / investigational in the US
Developed by Northwell Health, Early Treatment Program at Lenox Hill
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BIOLOGICAL

Indications

Trials

1
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
NCT02566057—Completed

KOLs & investigators

1
Jianping Zhang, MD, PhDKOL score 7

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
Northwell Health, Early Treatment Program at Lenox Hill
company
trial
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
NA
trial
indication
Schizophrenia
indication
Bipolar Disorder
indication
Schizophreniform Disorder
indication
Schizophrenia
indication
KOL
Jianping Zhang, MD, PhD
KOL score 7
person